Phosphorylation of Tau at Ser202 has been well characterized in AD, where staging of the disease is based on labeling of Ser202/Thr205 phosphorylation; increased phosphorylation at these sites is associated with an early degenerative modification of the cytoskeleton (29, 30). Here, MAPT is linked to Alzheimer disease.